GNRH1 and neoplasm: MHSPC are sensitive by definition to androgen deprivation [28,29,30,31], and thus suppression of testosterone to castrate levels by either orchiectomy or a long-acting LHRH agonist, results in a reduction in tumor cell division and metabolic activity.